CERS
Cerus Corporation Surpasses 24 Million Transfusible Doses Produced Worldwide, Demonstrates Solid Progress Across Growth, Innovation, and Financial Priorities
Cerus Corporation, a leading provider of blood safety solutions, has made significant strides in its mission to expand patient access to safe blood worldwide. During the second quarter of 2026, the company produced nearly 24 million transfusible doses globally, marking substantial progress towards its goal. According to Vivek Jayaraman, Cerus&